L-Glutathione

L-Glutathione is a low-molecular-weight tripeptide composed of three amino acids: L-glutamic acid (glutamate), L-cysteine, and glycine, linked through a unique gamma-peptide bond between the gamma-carboxyl group of glutamate and the amino group of cysteine. ^(1,2) This unusual bond structure, distinct from the standard alpha-peptide bonds found in proteins, confers resistance to most intracellular peptidases and is central to the molecule’s stability within the cell. ⁽²⁾ The compound has a molecular weight of 307.33 Da and is also known by its chemical designation GSH, its CAS number 70-18-8, and in supplement contexts as reduced glutathione.

The “L-” in L-glutathione refers to the natural levorotatory (left-handed) stereoisomer of the constituent amino acids, which is the biologically active configuration produced by living cells. ⁽¹⁾ In practical terms, L-glutathione and glutathione are the same compound. The distinction matters primarily in a laboratory context, where the D-isomer or racemic mixtures could, in principle, exist but have no biological relevance. When researchers, clinicians, or product labels refer to “glutathione,” they mean L-glutathione.

L-Glutathione is synthesized (also spelled synthesized in US literature) endogenously via a two-step, ATP-dependent pathway. The first step, catalyzed by gamma-glutamylcysteine synthetase (also known as glutamate-cysteine ligase), combines glutamate and cysteine. The second step, catalyzed by glutathione synthetase, adds glycine to complete the tripeptide. ⁽²⁾ The rate-limiting factor in this synthesis is typically the availability of cysteine, which is why cysteine precursors such as N-acetylcysteine (NAC) have been studied as an indirect means of boosting glutathione levels.

L-Glutathione is present in virtually every cell in the body, with particularly high concentrations in the liver, the primary organ responsible for detoxification. ^(1,2) Its intracellular concentration (1 to 10 mM) is orders of magnitude higher than its plasma concentration, reflecting its primary role as an intracellular protectant. Glutathione levels decline with age and are depleted by oxidative stress, chronic disease, exposure to environmental toxins, alcohol consumption, and certain medications. ^(1,4) This age-related decline has made glutathione supplementation a significant area of research interest in longevity, liver health, immune function, and dermatology.

It is important to distinguish L-glutathione from L-glutamine, a single amino acid with an entirely different molecular structure and biological function. Despite the similar-sounding names, these are unrelated compounds. L-glutamine (MW 146.14 Da) is an amino acid involved in nitrogen transport and immune cell fuel supply. At the same time, L-glutathione (MW 307.33 Da) is a tripeptide that functions as a redox buffer and a detoxification cofactor. ⁽¹⁾

Healius supplies L-glutathione as a lyophilized (also referred to as lyophilized in US research literature) powder in 600mg vials, intended strictly for laboratory and research applications.

L-Glutathione functions as the body’s primary thiol-based redox buffer through a reversible oxidation-reduction cycle. ^(1,2) In its reduced form (GSH), the cysteine residue’s thiol (-SH) group donates an electron to neutralize reactive oxygen species (ROS) and reactive nitrogen species (RNS). In the process, GSH is oxidized to glutathione disulfide (GSSG), in which a disulfide bond links two glutathione molecules. The enzyme glutathione reductase, using NADPH as a cofactor, then regenerates GSH from GSSG, completing the cycle. ⁽²⁾ The ratio of GSH to GSSG within a cell is one of the most widely used indicators of cellular redox status in experimental biology.

Beyond direct free radical scavenging, L-glutathione serves as an essential cofactor for several families of enzymes. Glutathione peroxidases (GPx) use GSH to reduce hydrogen peroxide and lipid hydroperoxides, protecting cell membranes from oxidative damage. ⁽¹⁾ Glutathione S-transferases (GSTs) catalyze the conjugation of GSH to electrophilic xenobiotics, drugs, and environmental toxins, facilitating their excretion through bile and urine as part of Phase II detoxification. ⁽³⁾ This conjugation pathway is a primary mechanism through which the body eliminates heavy metals (mercury, lead, cadmium, arsenic), drug metabolites, and carcinogenic compounds. ^(1,3)

L-Glutathione plays a critical role in mitochondrial protection. Mitochondria, as the primary source of endogenous ROS production during oxidative phosphorylation, are particularly vulnerable to oxidative damage. Mitochondrial GSH represents a distinct pool that is actively transported from the cytoplasm, and its depletion is associated with mitochondrial dysfunction, impaired ATP production, and activation of apoptotic pathways. ^(1,2)

In the immune system, glutathione supports the function of lymphocytes, natural killer (NK) cells, and other immune effector cells. Intracellular GSH levels influence T-cell proliferation, cytokine production, and the balance between Th1 and Th2 immune responses. ⁽⁵⁾ Research by Droge and Breitkreutz ⁽²⁰⁰⁰⁾ established that even moderate depletion of intracellular glutathione impairs lymphocyte function, while supplementation can enhance immune cell activity in subjects with depleted levels. ⁽⁵⁾

L-Glutathione also participates in protein folding and quality control within the endoplasmic reticulum, where the GSH: GSSG ratio governs the formation and isomerization (also spelled isomerization) of disulfide bonds in newly synthesized proteins. ⁽²⁾ Additionally, glutathione is involved in the regulation of ferroptosis, a form of iron-dependent programmed cell death driven by lipid peroxidation, positioning it as a molecule of significant interest in cancer biology and neurodegeneration research. ⁽¹⁾

The molecule also supports the recycling of other antioxidants, particularly vitamins C and E. Glutathione reduces oxidized vitamin C (dehydroascorbate) back to its active ascorbate form, and participates in the regeneration of vitamin E from its radical form, creating an interconnected antioxidant network within the cell. ^(1,3)

Skin lightening and anti-aging represent the most commercially visible applications of L-glutathione research, driven by significant consumer demand across Asian, African, and global markets. ^(6,7) The scientific basis for glutathione’s effects on skin pigmentation centers on two mechanisms: direct inhibition of tyrosinase, the rate-limiting enzyme in melanin biosynthesis, and a shift in melanogenesis from the production of darker eumelanin toward lighter pheomelanin. ^(6,7)

The landmark randomized, double-masked, placebo-controlled trial by Weschawalit et al. (2017), published in Clinical, Cosmetic and Investigational Dermatology, evaluated both reduced glutathione (GSH, 250mg/day) and oxidized glutathione (GSSG, 250mg/day) against placebo in healthy female volunteers over 12 weeks. ⁽⁷⁾ Both forms reduced melanin index and UV spots compared to placebo across all measured sites (face and arm), with the effects tending toward statistical significance. The study also documented improvements in skin elasticity, wrinkle reduction, and skin moisture in the glutathione groups. Both forms were well tolerated, with transient elevations in transaminases in two subjects that resolved spontaneously. ⁽⁷⁾

An earlier randomized, double-blind, placebo-controlled trial by Arjinpathana and Asawanonda (2012) used a higher oral dose of 500mg/day and reported a significant reduction in melanin indices after just four weeks of supplementation, with consistent reductions across six measured body sites. ⁽⁸⁾ The tolerance to glutathione was described as excellent. To further enhance systemic absorption, Handog et al. (2016) evaluated buccal lozenges containing 500mg glutathione in an open-label study of 30 Filipino women. They reported significant reductions in melanin index at both sun-exposed and sun-protected sites, with 90% of subjects achieving moderate skin lightening on global evaluation. ⁽⁹⁾

Topical glutathione has also shown promise. Etnawati et al.  ⁽²⁰¹⁹⁾ evaluated skincare formulations containing reduced glutathione at 0.1 to 0.5% concentrations and reported significant improvements in skin brightness and reduction in hyperpigmented lesions over eight weeks. ⁽¹⁰⁾ A 2025 systematic review by Sarkar et al. in the International Journal of Dermatology confirmed that topical glutathione at 0.5% was significantly more effective than 0.1% and placebo, with further improvement when combined with microneedling. ⁽¹¹⁾

A balanced interpretation of this evidence is essential. A 2025 narrative review published in Cureus (Alzahrani et al.) concluded that while oral glutathione shows significant but variable decreases in melanin levels with limited side effects, outcomes are inconsistent across studies, the optimal dosing and duration remain undefined, and the possibility of rebound hyperpigmentation upon discontinuation has been suggested but not formally studied. ⁽⁶⁾ The anti-aging effects, including wrinkle reduction and improved elasticity, documented in the Weschawalit trial, add a secondary dimension to glutathione’s dermatological interest beyond pigmentation alone. ⁽⁷⁾

Understanding the different forms of glutathione is critical for researchers designing protocols, as the form directly determines bioavailability, stability, and how the compound reaches the intracellular environment where it exerts its effects. ^(12,13)

Reduced L-glutathione (GSH) is the biologically active form that directly participates in redox reactions and enzymatic detoxification. However, oral GSH faces a significant bioavailability challenge: the tripeptide is susceptible to hydrolysis by gamma-glutamyltransferase (GGT) and other peptidases in the gastrointestinal tract, with published oral bioavailability estimated at below 1%. ⁽¹²⁾ A 2025 study by Yin et al. in Pharmaceutics measured the oral bioavailability of native GSH at just 0.7%, with a plasma half-life of approximately 2 minutes. ⁽¹²⁾ Despite this, multiple clinical trials using oral reduced glutathione at 250 to 500mg/day have demonstrated measurable biological effects on melanin index, wrinkle reduction, and immune markers, suggesting that even low systemic absorption produces detectable outcomes, or that local gastrointestinal effects contribute to the overall response. ^(7,8)

S-Acetyl L-glutathione (SAG) is a modified form in which an acetyl group is attached to the thiol group of the cysteine residue. ⁽¹³⁾ This acetylation increases the molecule’s stability in the gastrointestinal tract and its lipophilicity, allowing it to cross cell membranes intact. Once inside the cell, intracellular esterases remove the acetyl group, releasing active reduced glutathione. ⁽¹³⁾ A 2018 randomized, open-label crossover bioavailability trial by Fanelli et al., conducted in 18 healthy volunteers, found that SAG significantly increased the rate and extent of GSH absorption compared to oral reduced glutathione, with the acetyl group being rapidly deacetylated to GSH before reaching the bloodstream. ⁽¹³⁾

From a safety perspective, a comprehensive 2025 safety assessment published in Food and Chemical Toxicology evaluated SAG through a battery of tests. ⁽¹⁴⁾ The in vitro assays showed no genotoxic or mutagenic activity (negative Ames test and micronucleus assay). The acute oral toxicity study in rats yielded an LD50 greater than 2,000mg/kg. The 13-week repeated-dose study established a no-observed-adverse-effect level (NOAEL) of 1,500mg/kg/day. ⁽¹⁴⁾ These results support the safety of SAG for oral consumption.

A pilot study comparing oral S-acetyl glutathione (200mg/day for 7 days) against a single equivalent dose of intravenous glutathione found that the most significant oxidative stress marker, F2-isoprostane, was reduced more by the oral acetylated form than by IV administration, suggesting that SAG may provide comparable or superior intracellular glutathione replenishment to the IV route through a far more practical delivery method. ⁽¹⁵⁾

In summary, reduced GSH is the active form but has very poor oral bioavailability. S-acetyl L-glutathione offers enhanced stability, improved absorption, and efficient intracellular delivery. Both forms are relevant to research depending on the route of administration: for injectable research protocols, reduced GSH (as supplied in Healius 600mg vials) provides direct delivery that bypasses the oral bioavailability challenge entirely, while SAG is of particular interest for studies investigating oral or non-injectable delivery routes.

1. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine. 2009;30(1-2):1-12.

2. Lu SC. Regulation of glutathione synthesis. Molecular Aspects of Medicine. 2009;30(1-2):42-59.

3. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochemical Pharmacology. 2003;66(8):1499-1503.

4. Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition. 2018;72(1):105-111.

5. Droge W, Breitkreutz R. Glutathione and immune function. Proceedings of the Nutrition Society. 2000;59(4):595-600.

6. Alzahrani KA, et al. Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review. Cureus. 2025;17(1). PMC11862975.

7. Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects. Clinical, Cosmetic and Investigational Dermatology. 2017; 10:147-153.

8. Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-masked, placebo-controlled study. Journal of Dermatological Treatment. 2012;23(2):97-102.

9. Handog EB, Datuin MS, Singzon IA. An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women. International Journal of Dermatology. 2016;55(2):153-157.

10. Etnawati K, Adiwinarni DR, Susetiati DA, Sauchi Y, Ito H. The efficacy of skin care products containing glutathione in delivering skin lightening in Indonesian women. Dermatology Reports. 2019;11(1):4-6.

11. Sarkar R, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. International Journal of Dermatology. 2025. doi:10.1111/ijd.17535.

12. Yin N, Harris PWR, Liu M, et al. Enhancing the Oral Bioavailability of Glutathione Using Innovative Analog Approaches. Pharmaceutics. 2025;17(3):385.

13. Fanelli S, Francioso A, Cavallaro RA, et al. Oral Administration of S-acetyl-glutathione: Impact on the Levels of Glutathione in Plasma and in Erythrocytes of Healthy Volunteers. International Journal of Clinical Nutrition and Dietetics. 2018; 4:134.

14. Safety assessment of S-Acetyl Glutathione for use in foods and dietary supplements. Food and Chemical Toxicology. 2025. ScienceDirect.

15. Clinical Education. Oral Glutathione Equivalent to IV Therapy: Pilot study comparing oral S-acetyl glutathione vs IV glutathione on oxidative stress markers. Referenced in Clinical Education Review, 2011.

16. Regulatory approvals: CDSCO India (IV glutathione for alcoholic liver conditions); Philippine FDA (glutathione for cisplatin-associated neurotoxicity). Referenced in Alzahrani et al. 2025 and the Indian dermatology usage pattern study 2024.

17. BodyBio. Glutathione Injections: Are They Really Safe and Effective? Review citing 2025 research on injection side effects and liver dysfunction. September 2025.

18. Peptide dosage protocols: Subcutaneous L-glutathione 100-200mg daily, 600-1200mg weekly IV, 4–8-week cycles. Referenced in Peptides.org dosage guide and PeptideDosages.com protocol, 2025-2026.

This product is sold strictly for laboratory and research use only. It is not intended for human or animal consumption. It is not a dietary supplement, food, drug, or cosmetic. It is not intended to diagnose, treat, cure, or prevent any disease or condition. The buyer assumes all responsibility for the lawful use of this product in accordance with all applicable local, state, national, and international laws and regulations. By purchasing this product, the buyer confirms that they are a qualified researcher or are purchasing on behalf of a research institution.